We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+5.49%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$2.36B
AUM Growth
-$1.26B
Cap. Flow
-$1.38B
Cap. Flow %
-58.75%
Top 10 Hldgs %
65%
Holding
177
New
33
Increased
40
Reduced
38
Closed
36

Top Buys

Rank Stock Value
1
GLNG icon
Golar LNG
GLNG
+$33.5M
2
NVDA icon
NVIDIA
NVDA
+$32M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$26.7M
4
HPE icon
Hewlett Packard
HPE
+$22.9M
5
MASI
Masimo
MASI
+$18.6M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$31.8M
2
AAPL icon
Apple
AAPL
+$31.5M
3
KVUE icon
Kenvue
KVUE
+$27.7M
4
TKO icon
TKO Group
TKO
+$25M
5
PRMW
Primo Water Corporation
PRMW
+$19.6M

Sector Composition

Rank Sector Weight
1 Technology 14.94%
2 Healthcare 9.49%
3 Consumer Discretionary 8.47%
4 Communication Services 6%
5 Energy 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAS icon
151
Hasbro
HAS
$13.6B
-25,792
Closed -$1.51M
HUN icon
152
Huntsman Corp
HUN
$2B
-28,737
Closed -$654K
IAS
153
DELISTED
Integral Ad Science
IAS
-94,223
Closed -$916K
ILMN icon
154
Illumina
ILMN
$29.2B
-11,290
Closed -$1.18M
KVUE icon
155
Kenvue
KVUE
$37.9B
-1,524,600
Closed -$27.7M
LYRA
156
DELISTED
LYRA THERAPEUTICS INC
LYRA
-2,383
Closed -$33K
MDB icon
157
MongoDB
MDB
$25B
-12,342
Closed -$3.09M
MRCY icon
158
Mercury Systems
MRCY
$5.97B
-526,611
Closed -$14.2M
NABL icon
159
N-able
NABL
$818M
-49,845
Closed -$759K
NOVT icon
160
Novanta
NOVT
$5.04B
-11,497
Closed -$1.88M
PATH icon
161
UiPath
PATH
$6.32B
-142,000
Closed -$1.8M
PTON icon
162
Peloton Interactive
PTON
$2.84B
-2,226,862
Closed -$7.53M
RARE icon
163
Ultragenyx Pharmaceutical
RARE
$2.56B
-32,961
Closed -$1.35M
RCEL icon
164
Avita Medical
RCEL
$142M
-20,662
Closed -$164K
SBUX icon
165
Starbucks
SBUX
$118B
-21,000
Closed -$1.63M
SHC icon
166
Sotera Health
SHC
$5.06B
-143,826
Closed -$1.71M
SVV icon
167
Savers
SVV
$1.58B
-38,161
Closed -$467K
TEVA icon
168
Teva Pharmaceuticals
TEVA
$36.9B
-336,849
Closed -$5.47M
TWLO icon
169
Twilio
TWLO
$29.5B
-11,188
Closed -$636K
UEC icon
170
Uranium Energy
UEC
$4.67B
-77,463
Closed -$466K
WBD icon
171
Warner Bros
WBD
$64.2B
-15,352
Closed -$114K
XMTR icon
172
Xometry
XMTR
$4.58B
-276,710
Closed -$3.2M
XPOF icon
173
Xponential Fitness
XPOF
$282M
-156,022
Closed -$2.43M
DM
174
DELISTED
Desktop Metal, Inc.
DM
-92,255
Closed -$381K
PRMW
175
DELISTED
Primo Water Corporation
PRMW
-895,329
Closed -$19.6M

Similar funds

Clearline Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Clearline Capital held 177 positions worth $2.36B, down 35% from $3.62B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Clearline Capital withdrew a net $1.38B in Q3 2024, closing 36 positions and reducing 38 holdings. Its most notable exit was Apple, an estimated $31.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Clearline Capital opened a new position in Golar LNG worth $36.9M.

  • Clearline Capital's largest Q3 2024 buy was Golar LNG: 1,002,860 shares worth $36.9M.
  • Clearline Capital added most to MediaAlpha in Q3 2024, an estimated $10.6M increase.
  • Clearline Capital's biggest Q3 2024 reduction was Teladoc Health, cutting an estimated $31.8M.
  • Clearline Capital fully exited Apple in Q3 2024, selling an estimated $31.5M.
  • Clearline Capital's ten largest holdings make up 65% of its $2.36B portfolio in Q3 2024.
  • Clearline Capital opened 33 new positions and closed 36 in Q3 2024.
  • Clearline Capital's portfolio value fell 35% quarter-over-quarter to $2.36B.

Based on Clearline Capital's 13F filing for Q3 2024, filed 14 Nov 2024.